Can Ketamine Help With Bipolar Depression?

Author : Ross Tylor | Published On : 15 Sep 2026

Bipolar disorder can involve significant periods of depression, even when symptoms of mania or hypomania are under control. For some people, bipolar depression can be difficult to treat, particularly when standard medications do not provide enough relief.

This has led researchers to investigate whether ketamine can help with bipolar depression.

Ketamine is already well known for its rapid antidepressant effects in treatment-resistant depression. However, bipolar depression is different from major depressive disorder, and the evidence for ketamine is more limited. Early studies suggest that ketamine may reduce depressive symptoms in some people with bipolar depression, but it is not a first-line treatment and requires careful psychiatric evaluation and monitoring.

What Is Bipolar Depression?

Bipolar disorder is a mood disorder characterized by episodes of depression and periods of mania or hypomania. During a depressive episode, a person may experience symptoms such as:

• Persistent sadness or emptiness

• Loss of interest in activities

• Low energy and motivation

• Difficulty concentrating

• Changes in sleep

• Changes in appetite

• Feelings of worthlessness or guilt

• Social withdrawal

• Thoughts of death or suicide

Bipolar depression can be particularly challenging because treatment needs to account for the person's history of mood elevation as well as their depressive symptoms.

A medication that may be appropriate for unipolar depression is not automatically appropriate for bipolar depression. This is one reason treatment decisions should be made with a clinician familiar with bipolar disorder.

How Does Ketamine Work?

Ketamine works differently from traditional antidepressants. It primarily affects the brain's glutamate system by blocking NMDA receptors. This can influence communication between brain cells and may promote processes associated with neuroplasticity.

One of the features that makes ketamine particularly interesting is its relatively rapid antidepressant effect.

Traditional antidepressants often take several weeks to produce noticeable improvement. Research on ketamine has found that depressive symptoms can sometimes improve within hours or days.

Researchers are investigating whether this same rapid effect can occur during bipolar depressive episodes.

However, the mechanism does not mean ketamine simply "resets" the brain or permanently changes someone's mood. Its effects vary between individuals, and researchers are still studying why some patients respond while others do not.

Can Ketamine Help With Bipolar Depression?

Potentially, yes, but the evidence is still limited.

A 2023 systematic review examined eight studies involving 235 people with bipolar disorder. Across the studies, approximately 48% of participants receiving ketamine achieved a clinical response, compared with about 5% receiving placebo. Most intravenous ketamine studies used ketamine alongside an existing mood stabilizer. The review also reported that a small number of participants developed hypomanic or manic symptoms, highlighting the importance of monitoring.

These findings are encouraging, but they do not establish ketamine as a standard treatment for bipolar depression.

The relatively small number of participants, differences between studies, and limited long-term data mean that more large, controlled trials are needed.

What Does Research Say?

Research on ketamine for bipolar depression has produced some promising findings.

An earlier systematic review examined studies of intravenous ketamine in bipolar depression and found improvements in depressive symptoms across the included studies. However, the researchers also noted that the duration of benefit appeared relatively short and that additional research was necessary to determine the safest and most effective treatment schedules.

A more recent systematic review and meta-analysis examined both single and repeated ketamine or esketamine treatments. Eleven studies were included in the systematic review, with seven included in the meta-analysis. The pooled results from two randomized controlled trials showed significant improvements in depression scores one and two days after a single ketamine infusion.

Together, these findings suggest that ketamine deserves continued investigation, particularly for people whose bipolar depression has not responded adequately to other treatments.

But promising research is not the same as established treatment.

Why Is Ketamine Different for Bipolar Depression?

One of the biggest differences is the risk of mood switching.

People with bipolar disorder can experience mania or hypomania. Because ketamine has powerful effects on mood and brain activity, clinicians need to consider whether treatment could contribute to a switch into a manic or hypomanic state.

This does not mean ketamine inevitably causes mania.

In fact, several studies have reported relatively low rates of manic or hypomanic symptoms. The 2023 systematic review identified six participants across its pooled sample who developed hypomanic or manic symptoms after treatment.

The important point is that this risk needs to be assessed rather than ignored.

Is Ketamine Used With Mood Stabilizers?

In much of the research on ketamine for bipolar depression, ketamine has been administered as an add-on treatment while patients continued a mood-stabilizing medication.

This is an important distinction.

Ketamine should not be viewed as something a person should take instead of their prescribed bipolar medication without medical guidance. Stopping or changing mood stabilizers independently can increase the risk of mood instability.

A psychiatrist may consider a person's current medications, previous manic or hypomanic episodes, depressive severity, medical history, and previous treatment response before determining whether ketamine is appropriate.

Who Might Be Considered for Ketamine Treatment?

Ketamine may be considered in carefully selected patients with significant depressive symptoms, particularly when conventional treatments have not provided sufficient relief.

A clinician may look at:

1. Bipolar Diagnosis

The first step is confirming that the depression is actually part of bipolar disorder rather than unipolar major depression or another condition.

2. Previous Treatment Response

A person's history with medications and psychotherapy can help determine whether additional treatment strategies should be considered.

3. Current Mood Stability

A history of recent mania, hypomania, psychosis, or significant mood instability may affect whether ketamine is appropriate.

4. Current Medications

Clinicians need to know which mood stabilizers, antidepressants, antipsychotics, or other medications a patient is taking.

5. Physical Health

Blood pressure, cardiovascular history, substance use, and other medical factors can influence treatment decisions.

NeuroGlow's eligibility guide for ketamine treatment explains that bipolar depression can be considered under specific care protocols and emphasizes medical and psychiatric screening before treatment.

What Happens During Ketamine Treatment?

When IV ketamine is used, treatment is generally administered in a clinical environment under medical supervision.

The medication is delivered through an IV, and the patient is monitored during the session. Some people experience temporary changes in perception, dissociation, dizziness, drowsiness, nausea, or increases in blood pressure.

These effects usually resolve as the medication wears off, but patients should not assume that ketamine treatment is risk-free.

A responsible treatment program includes screening before treatment and monitoring during and after administration.

NeuroGlow's ketamine therapy information explains how ketamine has been investigated as a rapid-acting treatment for treatment-resistant depression and discusses the need for further research into long-term effectiveness and optimal treatment schedules.

Can Ketamine Cause Mania?

This is one of the most important questions for someone with bipolar disorder.

There is a potential risk of mania or hypomania, although available studies suggest that the risk may be relatively low when ketamine is carefully administered and patients are appropriately selected.

The 2023 systematic review found that five people receiving ketamine and one person receiving esketamine developed hypomanic or manic symptoms among the studies reviewed.

This does not mean that ketamine causes mania in everyone with bipolar disorder. It does mean that clinicians should actively monitor for changes in sleep, energy, impulsivity, irritability, racing thoughts, and unusually elevated mood.

Early recognition of mood elevation is particularly important because mania can escalate quickly in some people.

What About Suicidal Thoughts?

Bipolar depression can be associated with an increased risk of suicidal thoughts and behavior.

Some ketamine studies have reported reductions in suicidal ideation, but the evidence specific to bipolar depression remains limited. The 2023 systematic review found reductions in suicidal ideation in some studies, although not all results were statistically significant.

Ketamine should therefore not be presented as a guaranteed solution for suicidal thoughts.

Anyone experiencing immediate danger or an inability to stay safe should seek emergency psychiatric or medical assistance rather than waiting for a ketamine appointment.

Ketamine vs. Standard Bipolar Depression Treatment

Ketamine is not generally considered a replacement for established bipolar disorder treatments.

Depending on the individual, conventional treatment may include mood stabilizers, certain antipsychotic medications, psychotherapy, lifestyle support, and other evidence-based approaches.

Ketamine may be considered in specific circumstances when depressive symptoms remain difficult to manage.

The goal is not necessarily to replace an existing treatment plan. Instead, a psychiatrist may evaluate whether ketamine could have a role as part of a broader treatment strategy.

What Are the Limitations of Current Research?

There are several reasons to be cautious when interpreting the available evidence.

Small Study Sizes

Many ketamine studies for bipolar depression involve relatively small numbers of participants.

Limited Long-Term Data

Research has focused heavily on short-term symptom improvement. More research is needed to determine how long benefits can last and how repeated treatments should be managed.

Different Treatment Protocols

Studies may differ in ketamine dose, number of infusions, follow-up periods, and the medications participants take alongside ketamine.

Risk of Mood Switching

Although available evidence has not shown a consistently high rate of mania or hypomania, the possibility remains clinically important.

These limitations mean that ketamine for bipolar depression should still be considered an emerging treatment approach rather than a universally established one.

Could Ketamine Be Part of a Personalized Treatment Plan?

Possibly.

Mental health treatment is rarely one-size-fits-all. Two people with bipolar depression can have very different symptoms, medical histories, medication responses, and risks.

For one person, adjusting a mood stabilizer may be the appropriate next step. Another person may benefit from psychotherapy or a different medication. Someone with persistent, severe depression despite multiple treatments may be evaluated for additional options, potentially including ketamine.

As more research becomes available, discussions around emerging treatments for bipolar depression are increasingly appearing across health and wellness publishing platforms such as ArticlesCad, helping readers understand options that are still being studied.

The key is making treatment decisions based on clinical evaluation rather than assuming that a promising therapy is appropriate for everyone.

The Bottom Line

So, can ketamine help with bipolar depression?

Current research suggests that ketamine may provide rapid relief from depressive symptoms for some people with bipolar depression, particularly when used alongside a mood stabilizer and under careful psychiatric supervision. Several studies have reported meaningful short-term improvements, but the evidence base remains relatively small and more high-quality research is needed.

Ketamine is not a cure for bipolar disorder, and it should not replace established treatment without medical guidance. The potential for mood switching also makes careful screening and monitoring especially important.

For someone struggling with persistent bipolar depression, the most appropriate next step is a discussion with a qualified psychiatrist who can review the complete treatment history and determine whether ketamine or another evidence-based option makes sense.

This article is for educational purposes only and does not replace professional medical advice. Ketamine treatment for bipolar depression should only be considered following an appropriate medical and psychiatric evaluation.